公司資料
NeuroOne Medical Technologies 股價、新聞與催化劑
- 股票代碼:
- NMTC
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
2.14 USD (+5.42%)
收盤價
最後更新: 2026年8月24日
30.7M USD
市值
股價為何變動
As of Aug 24, 2026, NMTC closed up 5.42% at $2.14. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
NeuroOne Medical Technologies is a medical technology company focused on neurodiagnostic and neurosurgical tools. Its products are aimed at improving procedures and monitoring in the neurology and epilepsy workflow.
所在地與產業分類
NeuroOne is headquartered in the United States and listed on NASDAQ. It sits in medical devices rather than biotechnology.
商業模式特徵
The business depends on device adoption, hospital and physician workflow integration, and the ability to expand product utilization across neurological procedures. Investors watch capital sales, product clearances, and commercial execution.
生技產業定位
NeuroOne is part of the neurology-device layer of healthcare, not biotech. Its stock is driven by procedural adoption and product rollout rather than drug catalysts.
未來催化劑
- NeuroOne’s catalysts are minimally invasive neurology devices and adoption in epilepsy / neurosurgery workflows. The stock will respond to whether the installed base keeps expanding.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。